Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Supplementation and Metabolism in Vitamin D Deficient Elderly

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* 40-85 years of age~* Women must be post menopausal (absence of menses for 12 months or greater)~* 25-hydroxyvitamin D level below 20 ng/ml (50 nmol/L)~* BMI 25-45 kg/m2~* Non smoker ( non smoking for at least 12 months:cigarettes, cigars, pipes)~Exclusion Criteria:~* Symptomatic heart disease, CAD, CHF, or uncontrolled hypertension (BP over 180 mm HG) unless medically stabilized~* Currently being treated for active cancer~* Type 1 diabetes; insulin treatment for diabetes, poorly controlled diabetes, HgA1c \>10%~* Allergic to lidocaine~* History of seizures or taking anti-seizure or anti convulsion medications~* Untreated dyslipidemia with National Cholesterol ATPIII 10 year cardiac risk score greater than 10% (www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.htm)~* Taking oral steroids, warfarin or other medications interfering with fat/muscle metabolism that may not be safely discontinued temporarily for specific procedures (ie for 72 hours prior)~* Taking medication that interfere with ability to replete Vitamin D~* Abnormal liver function 2 times normal levels~* Abnormal renal function (BUN above 40 mg/dl, Cr above 1.8 mg/dl, CrCl\<60mg/dl)~* Hypercalcemia (Ca\>10.2mg/dl)~* Anemia HCT below 30 mg/dl, platelets below 100,000/cm3~* Chronic pulmonary disease (on supplemental O2)~* Other systemic disorders that are not medically treated and stable or affect the ability to absorb Vitamin D.~* MMSE below 24, dementia or unstable clinical depression by exam~* Abnormal response to exercise test (ST segment depression greater than 2mm, chest pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising BP above 240/120 mm HG, or other contraindications to exercise) \*requires follow up treatment w/ primary MD for continued participation in study~* Aerobically trained with VO2max greater than 2 SD above age-adjusted mean~* Participant is, in the opinion of the investigator, unable to adhere to the study protocol due to medical or orthopedic conditions that limit ability to exercise or travel to the Baltimore VA for protocol procedures.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- RDA Vitamin D (Type: ACTIVE_COMPARATOR): None
- Vit D repletion + 6M Supplementation (Type: EXPERIMENTAL): None
- Vit D repletion + 6M Supplementation +AEX (Type: EXPERIMENTAL): None
- Vit D repletion + 6M Supplementation +RT (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).